GALT Stock Analysis: Buy, Sell, or Hold?
GALT - Galectin Therapeutics Inc.
$3.83
0.71 (22.76%)
▲
5d:
+45.08%
30d:
+53.2%
90d:
+35.34%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When GALT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: GALT is 33.0% above its trading range ($2.88). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: GALT is 33.0% above its trading range ($2.88). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: GALT is currently trading at $3.83, which is considered extended relative to its 30-day fair value range of $2.28 to $2.88.
Technical Outlook: Technically, GALT is in a strong downtrend. The price is approaching resistance at $2.87. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 22.8% recently.
Market Sentiment: GALT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+252.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GALT is in a strong downtrend. The price is approaching resistance at $2.87. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 22.8% recently.
Market Sentiment: GALT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+252.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.28 -
$2.88
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
GALT is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+33.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+22.8%)
- BULLISH: Trading 252.6% below Wall St target ($11.00)
- WARNING: Recommendation downgraded due to 33.0% overvaluation
Trading Range Analysis
30-Day Trading Range
$2.28 -
$2.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.26
Resistance Level
$2.87
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.45
Wall Street Target
$11.00
(+252.6%)
Share & Embed Analysis
Last updated: June 24, 2026 12:22 PM ET
Data refreshes hourly during market hours. Next update: 1:22 PM
Data refreshes hourly during market hours. Next update: 1:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GALT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Kary Eldred
BUY
300 shares
2026-02-06
Jack W Callicutt
SELL
20354 shares
2026-01-06
Joel Lewis
SELL
37698 shares
2026-01-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced GALT Option Strategies
Professional options setups generated by AI based on today's GALT price and gamma walls.
